Selected article for: "acute respiratory syndrome coronavirus and low coverage"

Author: Hasan, Tasnim; Beardsley, Justin; Marais, Ben J.; Nguyen, Thu Anh; Fox, Greg J.
Title: The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines
  • Cord-id: 4vnz1si0
  • Document date: 2021_4_1
  • ID: 4vnz1si0
    Snippet: The global drive to vaccinate against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) began in December 2020 with countries in Europe, Middle East, and North America leading the roll out of a mass-vaccination program. This systematic review synthesised all available English-language guidelines and research regarding mass-vaccination for COVID-19 until 1 March 2021—the first three months of the global mass-vaccination effort. Data were extracted from national websites, PubMed, Emba
    Document: The global drive to vaccinate against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) began in December 2020 with countries in Europe, Middle East, and North America leading the roll out of a mass-vaccination program. This systematic review synthesised all available English-language guidelines and research regarding mass-vaccination for COVID-19 until 1 March 2021—the first three months of the global mass-vaccination effort. Data were extracted from national websites, PubMed, Embase, Medline and medRxiv, including peer and non-peer review research findings. A total of 15 national policy documents were included. Policies were summarised according to the World Health Organisation (WHO) framework for mass vaccination. All included policies prioritised front-line health care workers and the elderly. Limited information was available regarding staffing, cold chain, communication strategies and infrastructure requirements for effective vaccine delivery. A total of 26 research studies were identified, reporting roll-out strategies, vaccine uptake and reasons for refusal, adverse effects, and real-life estimates of efficacy. Early data showed a reduction in SARS-CoV-2 cases, hospitalisation and deaths in settings with good coverage. Very low rates of vaccine-related serious adverse events were observed. These findings provide an overview of current practice and early outcomes of COVID-19 mass-vaccination, guiding countries where roll-out is yet to commence.

    Search related documents:
    Co phrase search for related documents
    • abstract screen and low income country: 1
    • abstract screen and low income middle: 1, 2, 3, 4
    • abstract screen title and low income: 1
    • abstract screen title and low income country: 1
    • abstract screen title and low income middle: 1
    • abstract title and acute respiratory syndrome sars: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • abstract title and long term effect: 1
    • abstract title and low income: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • abstract title and low income country: 1, 2
    • abstract title and low income middle: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acceptance high rate and acute respiratory syndrome sars: 1, 2
    • active surveillance and acute respiratory syndrome sars: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active surveillance and local strategy: 1
    • active surveillance and low income: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • active surveillance and low income country: 1, 2
    • active surveillance and low income middle: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory syndrome sars and local strategy: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome sars and long term effect: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome sars and long term solution: 1, 2, 3